Investigational Drug Information for SCY-635
✉ Email this page to a colleague
What is the development status for investigational drug SCY-635?
SCY-635 is an investigational drug.
There have been 14 clinical trials for SCY-635.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2017.
The most common disease conditions in clinical trials are Candidiasis, Candidiasis, Vulvovaginal, and Candidiasis, Invasive. The leading clinical trial sponsors are Scynexis, Inc., Clinical Network Services (CNS) Pty Ltd, and ethica Clinical Research Inc.
There are one hundred and sixty-eight US patents protecting this investigational drug and two international patents.
Summary for SCY-635
| US Patents | 168 |
| International Patents | 2,386 |
| US Patent Applications | 308 |
| WIPO Patent Applications | 177 |
| Japanese Patent Applications | 132 |
| Clinical Trial Progress | Phase 3 (2017-11-15) |
| Vendors | 7 |
Recent Clinical Trials for SCY-635
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole | Scynexis, Inc. | Phase 3 |
| Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects | Clinical Network Services (CNS) Pty Ltd | Phase 1 |
| Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects | Scynexis, Inc. | Phase 1 |
Clinical Trial Summary for SCY-635
Top disease conditions for SCY-635
Top clinical trial sponsors for SCY-635
US Patents for SCY-635
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| SCY-635 | ⤷ Try a Trial | 1',4'-thio nucleosides for the treatment of HCV | IDENIX PHARMACEUTICALS LLC (Cambridge, MA) | ⤷ Try a Trial |
| SCY-635 | ⤷ Try a Trial | Benzimidazole derivatives | Enanta Pharmaceuticals, Inc. (Watertown, MA) | ⤷ Try a Trial |
| SCY-635 | ⤷ Try a Trial | Anti-viral compounds | AbbVie Inc. (North Chicago, IL) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SCY-635
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SCY-635 | European Patent Office | EP3004130 | 2033-06-05 | ⤷ Try a Trial |
| SCY-635 | World Intellectual Property Organization (WIPO) | WO2014197578 | 2033-06-05 | ⤷ Try a Trial |
| SCY-635 | Australia | AU2010217797 | 2029-02-27 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
